Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
Related Materials
This program addressed the available tools to identify these patients, explore resistance considerations in treatment decisions, and discuss how to tackle polypharmacy, drug-drug interactions, co-morbidities, and more!
Attendees gained insights into new treatment options and how best to integrate them into optimal antiretroviral regimens.
This webinar series was comprised of five editions, each in a different language, all featuring both regional and international experts.
We invite you to view the enduring materials from the following editions:
- German
- French
- Italian
- Spanish
- English
MD
National Hemophilia Center, Sheba Medical Center, Israel